Upcoming Events See all events >

Apr. 28, 2018 4:00 pm | Lake Eola Park

2018 Central Florida Walk to End Lupus Now

Join us in Orlando to raise money for lupus research, increase awareness of lupus, and rally public support.

May. 10, 2018 7:10 pm | Marlins Park

Lupus Awareness Night with the Miami Marlins

The Miami Marlins are excited to team up with the Lupus Foundation of America, Florida Chapter this year for our Lupus Awareness Night!

May. 20, 2018 2:00 pm | Riverside Arts Market

2018 North Florida Walk to End Lupus Now

Join us in Jacksonville to raise money for lupus research, increase awareness of lupus, and rally public support.

May. 29, 2018 7:00 pm | Teleconference

Lupus Making the Diagnosis Teleconference

The presentation will provide an overview of the ACR criteria, lupus signs and symptoms, and what a physician considers before making a diagnosis.

May. 31, 2018 5:30 pm | Children's Services Council

LIFE: Lupus Is A Full Experience


Latest News See all stories >

Mar. 22, 2018

Leading Lupus Experts Propose Actionable Solutions to Improve Clinical Trials

Announcing a new white paper, "Lupus Community Panel Proposals for Optimizing Clinical Trials: 2018," developed to address critical issues that have stymied the lupus drug development process for decades.

Mar. 22, 2018

Lupus Advocates Boost Funds for Lupus Research in Omnibus Appropriations Bill

The Omnibus Appropriations bill passed by the US House of Representatives on March 22 includes increased funding for critical lupus research and education programs.

Mar. 12, 2018

Grantee Spotlight: Tracoyia Roach, 2017 Gina M. Finzi Fellowship Recipient

Grantee Spotlight: Tracoyia Roach, 2017 Gina M. Finzi Fellowship Recipient

Feb. 21, 2018

NIH Datasets Will Accelerate the Quest for New Lupus Treatments

New datasets provide insight for cells in lupus and RA disease tissue.

Feb. 07, 2018

Atacicept Study Data Shows Promising Results

Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.